orally administered as a capsule. Approved in China by the National Medical Products Administration (NMPA) in November 2019, GV-971 became the first Alzheimer’s disease drug to be marketed since ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

The capsules are easy to swallow ... is worth trying for those looking for a choline supplement to aid in Alzheimer’s prevention. If you’re looking for a supplement that can help with ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...